Insiders Are Buying These 11 Penny Stocks
US stock market started the second quarter of 2024 in the red, driven by rising treasury yields, broader volatility and uncertainty around rate cuts as inflation remains sticky.
Summit Therapeutics Inc. (SMMT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lansdowne Partners Alex Snow | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.71 | 20,000 | Officer, Director | 50,000 | 2024-03-27 | Filing | |
| $3.75 | 30,000 | Officer, Director | 30,000 | 2024-03-26 | Filing | |
| $3.72 | 34,321 | Officer, Director | 24,923,800 | 2024-03-27 | Filing | |
| $3.72 | 26,000 | Officer, Director | 520,814 | 2024-03-27 | Filing | |
| $3.75 | 100,000 | Officer | 354,958 | 2024-03-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 13,713 | Officer | 0 | 2020-11-30 | Filing | |
| $4.39 | 29,569 | Officer | 0 | 2020-11-27 | Filing | |
| $4.32 | 12,070 | Officer | 0 | 2020-11-25 | Filing | |
| $4.21 | 11,374 | Officer | 0 | 2020-11-24 | Filing | |
| $4.40 | 6,987 | Officer | 0 | 2020-11-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,956 | $28,595 | 0.02% | |
| 2. | 527 | $1,375 | 0% |
News See All
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcript
Operator: Good morning and welcome to Summit's Fourth Quarter and Year End 2023 Earnings Call. [Operator Instructions] Please refer to the company's website for updates.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Summit Therapeutics Second Quarter 2023 Earnings Call. Please note that this call is being recorded. [Operator Instructions].
11 Stocks with Heavy Insider Buying in 2023
Insider trading activity has always invited interest and controversy from investors and authorities.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call. [Operator Instructions].
10 Best Stocks to Buy for a Quick Return
The stock market is made up of thousands of stocks, belonging to a wide variety of industries and sectors.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Brent, and I will be your conference operator today.
Hedge Fund and Insider Trading News: Angelo Gordon & Co., Elliott Management, Haidar Jupiter Fund, Antara Capital, Uniti Group Inc (UNIT), Occidental Petroleum Corporation (OXY), and More
Elliott Management has made it through to the second stage of the Manchester United bidding process but the Glazer family remain undecided on selling the club.
Billionaire Hedge Funds
